Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

696
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
696
Relative Risk01:12

Relative Risk

2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

482
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
482
Hazard Ratio01:12

Hazard Ratio

687
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
687
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

544
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
544
Contingency Table01:29

Contingency Table

4.8K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gradient boosting-based discrete failure time model for selecting time-varying effects and interactions.

Lifetime data analysis·2026
Same author

Artificial intelligence to improve the detection and risk stratification of acute pulmonary embolism (AID-PE): protocol for a pragmatic quasi-experimental comparator study.

BMJ open·2026
Same author

α/β for Hepatocellular Carcinoma Tumors Treated With Radiation Therapy.

International journal of radiation oncology, biology, physics·2026
Same author

KULLBACK-LEIBLER-BASED DISCRETE FAILURE TIME MODELS FOR INTEGRATION OF PUBLISHED PREDICTION MODELS WITH NEW TIME-TO-EVENT DATASET.

The annals of applied statistics·2026
Same author

Infection and telomere length: A systematic review.

PloS one·2025
Same author

Impact of neighbor-level disadvantage on survival outcomes in head and neck squamous cell carcinoma.

Cancer causes & control : CCC·2025
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Missing covariates in competing risks analysis.

Jonathan W Bartlett1, Jeremy M G Taylor2

  • 1Statistical Innovation Group, AstraZeneca Cambridge, UK jwb133@googlemail.com.

Biostatistics (Oxford, England)
|May 15, 2016
PubMed
Summary
This summary is machine-generated.

This study addresses missing covariate data in competing risks analysis. It validates complete case analysis and extends multiple imputation methods for more accurate results.

Keywords:
Competing risksMissing at randomMissing covariatesMultiple imputation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

998

Related Experiment Videos

Last Updated: Mar 21, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

998

Area of Science:

  • Biostatistics
  • Epidemiology
  • Survival Analysis

Background:

  • Competing risks data analysis is crucial in medical research.
  • Missing covariate data is a common challenge in these studies.
  • Complete case analysis (CCA) is a simple but often biased approach.

Purpose of the Study:

  • To establish conditions for valid complete case analysis (CCA) in competing risks.
  • To extend multiple imputation methods for handling missing covariates.
  • To compare the performance of CCA, substantive model compatible fully conditional specification (SMC-FCS) imputation, and other imputation methods in competing risks settings.

Main Methods:

  • Theoretical validation of complete case analysis (CCA) under specific conditions.
  • Extension of substantive model compatible fully conditional specification (SMC-FCS) imputation to competing risks.
  • Simulation studies and an illustrative data analysis to compare methods.

Main Results:

  • Conditions for the validity of complete case analysis (CCA) were established.
  • The extended SMC-FCS imputation method demonstrated potential for handling missing covariates.
  • Comparative analysis highlighted differences in performance between CCA and imputation methods.

Conclusions:

  • Complete case analysis (CCA) may be valid under certain assumptions in competing risks.
  • Multiple imputation, particularly extended SMC-FCS, offers a viable alternative for missing covariate data.
  • Careful consideration of missing data methods is essential for accurate competing risks analysis.